Publications by authors named "Pascal Morel"

Claim this Profile
E
Evaluation of assays for nucleic acid testing for the prevention of chikungunya and dengue virus transmission by blood transfusion.
Pierre Gallian, Isabelle Dupont, Marjorie Lacoste, Nadège Brisbarre, Christine Isnard, Pascal Morel

Transfusion· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Syphilis testing in blood donors, France, 2007 to 2022.
Syria Laperche, Claire Sauvage, Sophie Le Cam, Florence Lot, Lucile Malard, Pascal Morel

Euro Surveill· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New atypical epidemiological profile of parvovirus B19 revealed by molecular screening of blood donations, France, winter 2023/24.
Marlène Guillet, Ariane Bas, Marjorie Lacoste, Céline Ricard, Catherine Visse, Pascal Morel

Euro Surveill· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation of amotosalen plus ultraviolet A-mediated pathogen reduction for all platelet concentrates in France: Impact on the risk of transfusion-transmitted infections.
Pascale Richard, Elodie Pouchol, Imad Sandid, Laurent Aoustin, Caroline Lefort, Pascal Morel

Vox Sang· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human immunodeficiency virus, hepatitis C virus and hepatitis B virus incidence in blood donors from 2000 to 2020 in France: Trends and lessons from haemovigilance surveillance.
Syria Laperche, Claire Sauvage, Pierre Gallian, Saadia Jbilou, Elodie Pouchol, Pascal Morel

Vox Sang· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of covid-19 convalescent plasma to treat patients admitted to hospital for covid-19 with or without underlying immunodeficiency: open label, randomised clinical trial.
Karine Lacombe, Thomas Hueso, Raphael Porcher, Arsene Mekinian, Thibault Chiarabini, Pascal Morel

BMJ Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Experimental OFDM transmission performance analysis in a SOA - fiber cavity laser.
Raed El Hassanieh, Pascal Morel, Mohamad Hamze, Veronique Quintard, Andre Perennou

Opt Express· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving deferral criteria for blood donation in France: Plasma donation by men who have sex with men.
Pierre Tiberghien, Sophie Lecam, Julie Huet, Lucile Malard, Tristan Tavenard, Pascal Morel

Vox Sang· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low neutralization capacity against SARS-CoV-2 Omicron BQ.1.1 of convalescent plasma collected during circulation of Omicron BA.1.
Pierre Gallian, Nadége Brisbarre, Elif Nurtop, Sophie Le Cam, Touret Franck, Pascal Morel

Vox Sang· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 IgG seroprevalence surveys in blood donors before the vaccination campaign, France 2020-2021.
Pierre Gallian, Nathanaël Hozé, Nadège Brisbarre, Paola Mariela Saba Villarroel, Elif Nurtop, Pascal Morel

iScience· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seven years (2015-2021) of blood donor screening for HEV-RNA in France: lessons and perspectives.
Syria Laperche, Claude Maugard, Sébastien Lhomme, Sophie Lecam, Céline Ricard, Pascal Morel

Blood Transfus· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of vaccination on SARS-CoV-2 seroprevalence rate in French blood donors: An assessment as of July 2021.
Pierre Gallian, Ahmed Slimani, Lucile Malard, Pascal Morel, Xavier de Lamballerie

Transfus Clin Biol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seroprevalence surveys in blood donors population and complexity of immunization patterns.
Pierre Gallian, Nadége Brisbarre, Christine Isnard, Pascal Morel, Xavier de Lamballerie

Transfus Clin Biol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of donor ferritin testing on iron deficiency prevention and blood availability in France: A cohort simulation study.
Pascale Richard, Anne-Marie Fillet, Lucile Malard, Carole Leclerc, Claire Chanut, Pascal Morel

Vox Sang· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study.
Fabrice Cognasse, Hind Hamzeh-Cognasse, Mickael Rosa, Delphine Corseaux, Brigitte Bonneaudeau, Pascal Morel

EBioMedicine· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of a blood donation contaminated with hepatitis E virus entering the blood supply before the implementation of universal RNA screening in France.
Josiane Pillonel, Claude Maugard, Cécile Sommen, Julie Figoni, Chloé Pierre, Pascal Morel

Vox Sang· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights on 21 Years of HBV Surveillance in Blood Donors in France.
Pierre Cappy, Laure Boizeau, Daniel Candotti, Sophie Le Cam, Christophe Martinaud, Pascal Morel

Viruses· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory profile of convalescent plasma to treat COVID: Impact of amotosalen/UVA pathogen reduction technology.
Fabrice Cognasse, Hind Hamzeh-Cognasse, Anne-Claire Duchez, Natalia Shurko, Marie-Ange Eyraud, Pascal Morel

Front Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 and post-donation information: a one-year experience of the French haemovigilance network.
Pierre Cappy, Saadia Legrain-Jbilou, Lila Chabli, Melissa N'Debi, Pierre Gallian, Pascal Morel

Blood Transfus· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Description and validation of a new, simple, easy-to handle, point-of-care technique for measuring erythrocyte aggregation kinetics.
Olivier L Charansonney, Pascal Morel, Jacques Dufaux, Eric Vicaut

Sci Rep· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced neutralizing antibody potency of COVID-19 convalescent vaccinated plasma against SARS-CoV-2 Omicron variant.
Pierre Gallian, Abdennour Amroun, Syria Laperche, Sophie Le Cam, Nadège Brisbarre, Pascal Morel

Vox Sang· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
Jérémy Manry, Paul Bastard, Adrian Gervais, Tom Le Voyer, Jérémie Rosain, Pascal Morel

Proc Natl Acad Sci U S A· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis.
Thomas Hueso, Anne-Sophie Godron, Emilie Lanoy, Jérôme Pacanowski, Laura I Levi, Pascal Morel

Leukemia· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low rate of RNAemia in blood donations collected during the first wave of COVID-19 in France.
Sophie Le Cam, Pierre Gallian, Céline Ricard, Céline Narboux, Valérie Barlet, Pascal Morel

Transfusion· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies.
Jeremy Manry, Paul Bastard, Adrian Gervais, Tom Le Voyer, Jérémie Rosain, Pascal Morel

Res Sq· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis